1. LiPuma J.J. Burkholderia and emerging pathogens in cystic fibrosis. Semin. Respir. Crit. Care Med. 2003; 24: 681–692.

2. Hoiby N., Pressler T. Emerging pathogens in cystic fibrosis. Cyst. Fibros. Monograph. 2006; 35 (11): 66–78.

3. Муковисцидоз. Ранняя диагностика и лечение. / Капранов Н.И., Каширская Н.Ю., Толстова В.Д. и др. М.: ГЭОТАР-Медиа; 2008.

4. Early intervention and prevention of lung disease in cystic fibrosis: a European Consensus. J. Cyst. Fibros. 2004; 3 (2): 67–91.

5. Smyth A. Update on treatment of pulmonary exacerbation in cystic fibrosis. Curr. Opin. Pulm. Med. 2006; 12: 440–444.

6. Goss C.H., Otto K., Aitken M.L. et al. Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 2002; 166: 356–361.

7. Goss C.H., Mayer*Hamblett N., Aitken M.L. et al. Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis. Thorax 2004; 59: 955–959.

8. Cystic fibrosis in children and adults. The Leeds method of management.: St. James's University Hospital, UK; 2008. November 7.

9. de Baets F., Schelstraete P., van Daele S. et al. Achromobacter хylosoxidans in cystic fibrosis: prevalence and clinical relevance. J. Cyst. Fibros. 2007; 6 (1): 75–78.

10. Brown B. et al. In: The 22th Annual North American Cystic Fibrosis Foundation Conference (NACFC). Orlando, Florida; 2008; abs. 359.

11. Hansen C.R., Pressler T., Nielsen K.G. et al. Inflammation in Achromobacter хylosoxidans infected cystic fibrosis patients. J. Cyst. Fibros. 2010; 9 (1): 51–58.

12. Van Daele S., Verhelst R., Claeys G. et al. Shared genotypes of Achromobacter хylosoxidans strains isolated from patients at cystic fibrosis rehabilitation center. J. Clin. Microbiol. 2005; 43: 2998–3002.

13. Balfour*Lynn I.M., Elborn J.S. Respiratory disease: infection. In: Hodson M., Geddes D., Bush A., eds. Cystic fibrosis, 3rd ed. London; 2007. 137–159.

14. Lee T.W., Brownlee K.G., Conway S.P. et al. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J. Cyst. Fibros. 2003; 2: 29–34.